TBTA

CAS No. 510758-28-8

TBTA( —— )

Catalog No. M18691 CAS No. 510758-28-8

TBTA is a tertiary amine with three 1, 2, 3-triazole groups. It complexes with, and stabilizes, copper(I) to accelerate azide-alkyne cycloadditions, as used in click chemistry.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 29 In Stock
10MG 43 In Stock
25MG 70 In Stock
50MG 97 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    TBTA
  • Note
    Research use only, not for human use.
  • Brief Description
    TBTA is a tertiary amine with three 1, 2, 3-triazole groups. It complexes with, and stabilizes, copper(I) to accelerate azide-alkyne cycloadditions, as used in click chemistry.
  • Description
    TBTA is a tertiary amine with three 1, 2, 3-triazole groups. It complexes with, and stabilizes, copper(I) to accelerate azide-alkyne cycloadditions, as used in click chemistry.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    510758-28-8
  • Formula Weight
    530.62
  • Molecular Formula
    C30H30N10
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (188.46 mM)
  • SMILES
    C(N(Cc1cn(Cc2ccccc2)nn1)Cc1cn(Cc2ccccc2)nn1)c1cn(Cc2ccccc2)nn1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Hong V, et al. Electrochemically Protected Copper(I)-Catalyzed Azide-Alkyne Cycloaddition[J]. Chembiochem, 2008, 9(9):1481-1486.
molnova catalog
related products
  • (R)-Carisbamate

    (R)-Carisbamate is the R-isomer of Carisbamate .?Carisbamate is an experimental anticonvulsant drug.

  • LY2955303

    LY2955303 is an effective and selective antagonist of retinoic acid receptor gamma (RARγ, Ki = 1.09 nM).

  • TT01001

    TT01001 is a selective agonist of mitoNEET and reduces oxidative stress injury and neuronal apoptosis by improving mitochondrial dysfunction. TT01001 can be used in studies about the treatment of type II diabetes.